Shadman M, Salkar M, Srivastava B, Karve S, et al. Real-world outcomes following ibrutinib dose reduction in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Leuk Lymphoma 2024 Oct 1:1-10. doi: 10.1080/10428194.2024.2402814.
PMID: 39352001